UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure

European journal of drug metabolism and pharmacokinetics, 2019-02, Vol.44 (1), p.1-12

Padrini, Roberto

2019

Volltextzugriff (PDF)

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

Blood, 2008-04, Vol.111 (7), p.3540-3545

2008

Volltextzugriff (PDF)

Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products

Toxicology reports, 2017-01, Vol.4, p.234-239

2017

Volltextzugriff (PDF)

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

Pharmacogenetics and genomics, 2006-02, Vol.16 (2), p.101-110

2006

Volltextzugriff (PDF)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation

PloS one, 2015-12, Vol.10 (12), p.e0145318-e0145318

2015

Volltextzugriff (PDF)

Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism

Blood pressure, 2018-07, Vol.27 (4), p.200-205

2018

Volltextzugriff (PDF)

Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction

Frontiers in pharmacology, 2020-12, Vol.11, p.602369

2020

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial

European journal of clinical pharmacology, 2018-05, Vol.74 (5), p.571-582

2018

Volltextzugriff (PDF)

Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors

Frontiers in pharmacology, 2018-02, Vol.9, p.59-59

2018

Volltextzugriff (PDF)

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Haematologica (Roma), 2010-08, Vol.95 (8), p.1366-1372

2010

Volltextzugriff (PDF)

R‐warfarin anticoagulant effect

British journal of clinical pharmacology, 2017-10, Vol.83 (10), p.2303-2304

2017

Volltextzugriff (PDF)

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Clinical chemistry (Baltimore, Md.), 2002-06, Vol.48 (6), p.850-858

2002

Volltextzugriff (PDF)

Correlations between the enantio- and regio-selective metabolisms of warfarin

Pharmacogenomics, 2017-01, Vol.18 (2), p.133-142

2017

Volltextzugriff (PDF)

Relationships between body composition parameters and fluorouracil pharmacokinetics

British journal of clinical pharmacology, 2002-08, Vol.54 (2), p.131-139

2002

Volltextzugriff (PDF)

Unduly Enhanced Response to Tolvaptan in a Woman Showing Syndrome of Inappropriate Antidiuretic Hormone Secretion: An Investigation of Possible Causes

AACE clinical case reports, 2017-01, Vol.3 (4), p.357-360

2017

Volltextzugriff (PDF)

Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes

European journal of clinical pharmacology, 2017-06, Vol.73 (6), p.699-707

2017

Volltextzugriff (PDF)

Dosing of clopidogrel and aspirin in acute coronary syndromes

The New England journal of medicine, 2010-12, Vol.363 (25), p.2465

2010

Volltextzugriff (PDF)

A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease

Thrombosis and haemostasis, 2018-02, Vol.118 (2), p.309

2018

Volltextzugriff (PDF)

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)‐ibuprofen

Chirality (New York, N.Y.), 2021-06, Vol.33 (6), p.281-291

2021

Volltextzugriff (PDF)

DOAC plasma levels measured by chromogenic anti‐Xa assays and HPLC‐UV in apixaban‐ and rivaroxaban‐treated patients from the START‐Register

International journal of laboratory hematology, 2020-04, Vol.42 (2), p.214-222

2020

Volltextzugriff (PDF)

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S

Chirality (New York, N.Y.), 2021-06, Vol.33 (6), p.281

2021

Volltextzugriff (PDF)

A model-based approach to the automatic diagnosis of von Willebrand disease

AIChE journal, 2014-05, Vol.60 (5), p.1718-1727

2014

Volltextzugriff (PDF)

Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease

Seminars in thrombosis and hemostasis, 2011-07, Vol.37 (5), p.456

2011

Volltextzugriff (PDF)

Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders

Journal of hypertension, 2016-01, Vol.34 (1), p.20-28

2016

Volltextzugriff (PDF)

Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms

Cancer chemotherapy and pharmacology, 2019-03, Vol.83 (3), p.493-500

2019

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation

Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism

Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction

Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial

Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

R‐warfarin anticoagulant effect

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Correlations between the enantio- and regio-selective metabolisms of warfarin

Relationships between body composition parameters and fluorouracil pharmacokinetics

Unduly Enhanced Response to Tolvaptan in a Woman Showing Syndrome of Inappropriate Antidiuretic Hormone Secretion: An Investigation of Possible Causes

Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes

Dosing of clopidogrel and aspirin in acute coronary syndromes

A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)‐ibuprofen

DOAC plasma levels measured by chromogenic anti‐Xa assays and HPLC‐UV in apixaban‐ and rivaroxaban‐treated patients from the START‐Register

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S

A model-based approach to the automatic diagnosis of von Willebrand disease

Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease

Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders

Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms

Suchergebnisse filtern